Penile Duplex Ultrasonography in Men with Peyronie's Disease: Is it Veno-Occlusive Dysfunction or Poor Cavernosal Arterial Inflow that Contributes to Erectile Dysfunction?

Journal of Sexual Medicine

Volumn 8, Issue 12, 2011, Pages 3446-3451

  Chung, Eric ^a   De Young, Ling ^b   Brock, Gerald B ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Division of Urology   (Canada)

Author keywords

Cavernosal arterial insufficiency; Corporal veno occlusive dysfunction; Duplex ultrasonography; Erectile dysfunction; Peyronie's disease

Indexed keywords

PROSTAGLANDIN E1;

ADOLESCENT; ADULT; AGED; ARTERY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CIGARETTE SMOKING; COLOR DUPLEX ULTRASONOGRAPHY; COLOR ULTRASOUND FLOWMETRY; COMORBIDITY; CORONARY ARTERY DISEASE; CORPUS CAVERNOSUM; DIABETES MELLITUS; DISEASE COURSE; ECHOGRAPHY; ERECTILE DYSFUNCTION; FIBROSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOPHYSIOLOGY; PENILE BLOOD FLOW; PENIS DISEASE; PEYRONIE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TUNICA ALBUGINEA; TUNICA MEDIA;

EID: 82955208602     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02501.x     Document Type: Article

References (25)

1. Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L. The management of Peyronie's disease: Evidence-based 2010 guidelines. J Sex Med 2010;7:2359-74.
2. Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: New insights into the cellular and molecular pathology of Peyronie's disease. Nat Clin Pract Urol 2005;2:291-7.
3. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstrom W. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004;171:2350-3.
4. Rosen R, Catania J, Lue T, Althof S, Henne J, Hellstrom W, Levine L. Impact of Peyronie's disease on sexual and psychosocial functioning: Qualitative findings in patients and controls. J Sex Med 2008;5:1977-84.
5. Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, Sharlip I, Althof SE, Andersson KE, Brock G, Broderick G, Burnett A, Buvat J, Dean J, Donatucci C, Eardley I, Fugl-Meyer KS, Goldstein I, Hackett G, Hatzichristou D, Hellstrom W, Incrocci L, Jackson G, Kadioglu A, Levine L, Lewis RW, Maggi M, McCabe M, McMahon CG, Montague D, Montorsi P, Mulhall J, Pfaus J, Porst H, Ralph D, Rosen R, Rowland D, Sadeghi-Nejad H, Shabsigh R, Stief C, Vardi Y, Wallen K, Wasserman M. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2010;7:3572-88.
6. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Aging Study. J Urol 2000;163:460-3.
7. El-Sakka AI, Hassoba HM, Pillaritsetty RJ, Dahiya R, Lue TF. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997;158:1391-4.
8. Tomasek JJ, Gabbiani G, Hinz B, Chapponier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3:349-63.
9. Gonzalez-Cadavid NF. Mechanism of penile fibrosis. J Sex Med 2009;6:353-62.
10. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of penis. Clin Radiol 2003;58:514-23.
11. Lopez JA, Jarow JP. Duplex ultrasound findings in men with Peyronie's disease. Urol Radiol 1991;12:199-202.
12. Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph D, Stackl W. Peyronie's disease. J Sex Med 2004;1:110-5.
13. Ferrini M, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Aging-related expression of inducible nitric oxide synthase (iNOS) and markers of tissue damage in the rat penis. Biol Reprod 2001;64:974-82.
14. Traish AM, Munarriz R, O'Connell L, Choi S, Kim SW, Kim NN, Huang YH, Goldstein I. Effects of medical or surgical castration on erectile function in an animal model. J Androl 2003;24:381-7.
15. Kovanecz I, Rambhatla A, Ferrini MG, Verdet D, Sanchez S, Rajfer J, Gonzalez-Cadavid NF. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008;101:203-10.
16. Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Umeh C, Rajfer J, Gonzalez-Cadavid NF. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CCVOD) induced by experimental cavernosal nerve damage in the rat. J Sex Med 2009;6:415-28.
17. Davila HH, Rajfer J, Gonzalez-Cadavid NF. Corporal veno-occlusive dysfunction in the aging rat. Evaluation by cavernosometry and cavernosography. Urology 2004;64:1261-6.
18. Brock G, Hsu GL, Nunes L, von Heyden B, Lue TF. The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J Urol 1997;157:276-81.
19. Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM. Proposal trauma as the cause of the Peyronie's lesion. J Urol 1997;157:285-90.
20. Smith JF, Brant WO, Fradet V, Shindel AW, Vittinghoff E, Chi T, Huang YC, Davis CB, Conti S, Lue TF. Penile sonographic and clinical characteristic in men with Peyronie's disease. J Sex Med 2006;6:2858-67.
21. Breyer BN, Shindel AW, Huang YC, Eisenberg ML, Weiss DA, Lue TF, Smith JF. Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease? J Urol 2010;183:1484-8.
22. Mulhall JP, Nicholson B, Pierpaoli S, Lubrano T, Shankey TV. Chromosomal instability is demontrstaed by fibroblasts derived from tunica of men with Peyronie's disease. Int J Impot Res 2004;16:288-93.
23. Vernet D, Nolazco G, Cantini L, Magee TR, Qian A, Rajfer J, Gonzalez-Cadavid NF. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: Implications for Peyronie disease. Biol Reprod 2005;73:1199-210.
24. Andresen R, Wegner HE, Banzer D, Miller K. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease. Acta Radiol 1996;37:352-6.
25. Bekos A, Arvaniti M, Hatzimouratidis K, Moysidis K, Tzortzis V, Hatzichristou D. The natural history of Peyronie's disease: An ultrasonography-based study. Eur Urol 2008;53:644-50.